Exploring the latest news and insight around cell and gene therapy, including new technology and information on treatments. See how pharma is leveraging gene therapy and cell therapy to prevent and treat disease.
Neuro-focused Encoded Therapeutics has bagged a $275 million series F round to support its Dravet syndrome asset and scale up its internal manufacturing capabilities.